INTRODUCTION
Elevated plasma cholesterol affects nearly 100 million Americans, a third of the US population, resulting in devastating health consequences and nearly one million deaths annually. Although the long-term effect of elevated plasma cholesterol is known for its accretion in arterial walls, little was understood of its immediate effects until recently (Jena and Lee, 2010) . Cholesterol in blood plasma is known to rapidly enter and incorporate into the red blood cell (RBC) plasma membrane (Tall, 1993; Glomset et al., 1995; Ishizake et al., 1994) . As early as the 1970s, it was demonstrated in human studies that blood plasma and RBC membrane cholesterol levels are inversely associated with the transmembrane O 2 diffusion rate of RBC (Steinbach et al., 1974) : as cholesterol levels in the blood plasma and consequently in the RBC membrane decrease, O 2 diffusion in RBC increases (Steinbach et al., 1974; Menchaca et al., 2004) . Then in 2010 (Jena and Lee, 2010) , we reported for the first time that the immediate effect of elevated plasma cholesterol is dysfunction of active water and CO 2 transport via the AQP1 channel through the RBC membrane. The effect of the phospholipase A2 (PLA2) inhibitor ONO-RS-082 (ONO) on ameliorating the detrimental effects of cholesterol was further demonstrated from that study (Jena and Lee, 2010) .
In the past decade, the tetradecapeptide wasp venom mastoparan, GTP, the GTP-binding heterotrimeric Gα i / Gα o proteins, vH + -ATPase, PLA2, the K + and Cl -channels, and aquaporins (Abu-Hamdah et al., 2004) , have been implicated in the gating of water into secretory vesicles. A similar mechanism operating at the RBC membrane is therefore hypothesized. Gα i3 has been implicated in various tissues to regulate both K + and Cl -ion channels at the plasma membrane (Delport et al., 1997; Knepper and Inoue, 1994, 1997) . PLA2 has also been found to regulate both K + and Cl -ion channels. Since Gα i3 and PLA2 are present at the RBC membrane (Mukherjee and Maxfield, 2004; Hillman et al., 2005) , I hypothesize the involvement of both Gα i3 and PLA2 in the regulation of AQP1 activity. Furthermore, since K + and Cl -ion channels are present at the RBC membrane (Hillman et al., 2005) Diet, lifestyle, and genetics contribute to a staggering 100 million people, nearly a third of the population, suffering from elevated blood cholesterol levels in the USA. Though cholesterol is essential for numerous physiological functions, it is well documented that the long-term effects of elevated levels of plasma cholesterol pose a significant health risk and are causal factors for diseases including angina, cardiovascular disorders and diabetes, resulting in more deaths than cancer and HIV combined. The short-term effect of elevated plasma cholesterol is, however, little known. Our earlier studies report that elevated plasma membrane cholesterol is detrimental to water and CO 2 transport in erythrocytes or red blood cells (RBC), and that this transport is mediated via the water channel AQP1. In the current study, the dysfunction of active water and CO 2 transport via the AQP1 channel through the RBC membrane is further confirmed. 
MATERIALS AND METHODS
RBC were isolated according to our published procedure (Jena and Lee, 2010) . To determine the rôle of cholesterol on AQP1-induced rapid gating of water into RBC, cholesterol was incorporated into the plasma membrane of isolated RBC also according to our published procedure (Jena and Lee, 2010) . The transport of CO 2 into RBC was determined using an established BCECF fluorescence assay (Fig. 1) . The presence of AQP1 and the regulatory components involved in its function at the RBC membrane were determined using immunoblot and immunoprecipitation assays (Fig. 2) . Mastoparan is a G-protein stimulator, which has been demonstrated to stimulate AQP1-induced RBC swelling (Jena and Lee, 2010) , and was used in the study. Real-time changes in RBC size were determined using the established right-angle dynamic light scattering (DLS) technique (Jena and Lee, 2010) . To discount the effect of passive water transport, all DLS experiments to determine the relative size dynamics of RBC were carried out in water. Student's t-test was used to quantitatively compare groups, with significance deemed to be established at P < 0.01.
Isolation of rat red blood cells: RBC were isolated according to a published procedure (Jena and Lee, 2010) . Briefly, male Sprague-Dawley rats weighing 100-120 g were used for the study. Blood was collected by cardiac puncture immediately following CO 2 -induced euthanasia of the animal. The blood sample was diluted in 10 volumes of PBS, and spun at 120 g for 10 min at 4 °C. The resulting pellet was resuspended in 2 volumes of PBS and washed three times, followed by final resuspension in 10 volumes of PBS prior to use.
Cholesterol reconstitution into the RBC membrane: RBC membrane was reconstituted with excess cholesterol using a published procedure (Jena and Lee, 2010) . Following incubation of RBC at room temperature for 30 min in buffer containing 40 μM cholesterol (Sigma-Aldrich, St. Louis, Missouri), the cells were lysed using sonication and centrifuged for 1 h at 100 000 g to obtain the cell plasma membrane. The RBC plasma membrane, obtained as a pellet, was solubilized using 1% w / v Triton-Lubrol mixture, and assayed for cholesterol and protein content (data not shown). Cholesterol content was measured using an Amplex Red Cholesterol Assay Kit (Molecular Probes) according to the manufacturers' instructions. Protein concentrations were assayed using the Pierce BCA protein assay kit (Thermo Scientific, Rockford, Illinois) (Smith et al., 1985) .
Determination of the optimal dose of various compounds used for the regulation of RBC swelling due to rapid water entry: Dose-response experiments using various compounds used DLS to assess RBC volume.
Optimal doses of the water channel stimulator mastoparan (Mas), the water channel inhibitor HgCl 2 , cholesterol (CHOL), the chloride channel inhibitor diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS), the potassium channel inhibitor Glyburide (GLY) (Glucovance®; Bristol-Myers Squibb), and the vH-ATPase inhibitor Bafilomycin, were then used in the study.
BCECF-AM measurement of CO 2 transport across the RBC membrane: Freshly prepared and washed RBC were labelled with the acetoxymethyl ester of BCECF (BCECF-AM, Molecular Probes), by incubation with 20 mM BCECF-AM in PBS at 22 °C for 20 min. External dye were removed by five washes (100 g, 10 min), and the labelled RBC were maintained on ice until measurements were made. Examination of cells by fluorescence microscopy helped determine the uniformity of labelling, and the absence of leukocytes (which are larger and brightly labelled). The BCECF-labelled RBC suspension was either untreated or treated with cholesterol or HgCl 2 and incubated for 15 min in a sealed flask containing CO 2 . BCECF fluorescence was monitored at an excitation wavelength of 485 nm and detected at 515 nm using a Hitachi F-2000 spectrofluorimeter (Fig. 1) .
Western blot analysis and immunoisolation of AQP1-associated proteins at the RBC membrane: Isolated RBC were lysed using sonication and centrifuged for 1 h at 100 000 g to obtain the cell plasma membrane. The RBC plasma membrane, obtained as a pellet, was solubilized using a 1% w / v Triton-Lubrol mixture and mixed with an equal volume of Laemmli sample preparation buffer, prior to the one-dimensional 10% SDS-PAGE, electrotransfer to nitrocellulose and immunoblot analysis using specific antibodies to AQP1 (Santa Cruz Biotechnology Inc., Santa Cruz, California). To immunoisolate the RBCmembrane AQP1 and associated proteins, the 1% w / v Triton-Lubrol-solubilized RBC membrane was immunoisolated using specific antibodies to AQP1 conjugated to protein G-sepharose beads (Santa Cruz Biotechnology Inc.). The resultant immunoisolates was resolved using 10% SDS-PAGE, electrotransfer to nitrocellulose and immunoblotting using a specific antibody against potassium and chloride channels, and vH-ATPase. Ten micrograms of total RBC membrane (RBCM) protein solubilized in 1% Triton-Lubrol, and 100 μg of RBCM immunoprecipitated using AQP1-specific antibody (RBCM-IP-AQP1), were resolved using 10% SDS-PAGE, followed by electrotransfer to nitrocellulose membrane, and probed using vH-ATPase-, KiR6.1 (potassium channel)-, and CLC3 (chloride channel)-specific antibodies (Santa Cruz Biotechnology Inc.).
Dynamic light scattering of RBC: Measurements of RBC size dynamics were determined using real-time, right-angle light scattering in a Hitachi F-2000 spectrofluorimeter (Jena and Lee, 2010) . Real-time scattered light intensities at excitation and emission wavelengths of 530 nm were used to measure the size dynamics of RBC. The amount of light emitted from the sample at the emission wavelength is directly proportional to the surface area of the RBC, which increases as the volume increases due to water being transported into the cell. In these experiments, isolated RBC were suspended in water and rapid changes in their size was monitored before and after addition of HgCl 2 (an AQP1 inhibitor) and CHOL, followed by Mas exposure.
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Results are expressed in arbitrary units and as percent light scattered over controls. Student's t-test was performed for comparison between groups, with significance set at P < 0.05.
Order-specific blocker analysis to determine the signalling pathway involved in AQP1 regulation at the RBC membrane: The various combinations of the sequential application of 40 mM of either the chloride or potassium channel inhibitors or the PLA2 inhibitor (ONO-RS-082), on Mas-induced RBC water entry and swelling were analysed. RBC were exposed to the chloride channel inhibitor DIDS followed by the potassium channel inhibitor GLY, and to GLY followed by DIDS. Similarly experiments were performed using DIDS preceding exposure of RBC to ONO-RS-082 and the reverse sequence; and exposure first to GLY followed by ON-ORS-082 and the reverse combination, to determine which of them comes before the other in the signalling cascade. Three separate experiments were performed for each combination, with 8-15 recorded points per experiment, which were averaged and represented with their standard deviations in the results (Fig. 5) .
RESULTS AND DISCUSSION
RBC from rat blood was isolated for the study and its purity determined by both light microscopy and scanning electron microscopy (data not shown). Both light and electron micrographs of the isolated RBC demonstrated an intact and homogeneous preparation. To discount the effect of passive water transport into or out of the RBC due to osmosis, all dynamic light scattering (DLS) experiments to determine the rapid size dynamics of RBC were performed in water. Under these conditions and experimental time window, no change in nonstimulated or osmotic water transport was observed, as previously demonstrated (Jena and Lee, 2010) . Furthermore, to determine whether exposure of RBC to CHOL results in its incorporation into the RBC membrane, CHOL was measured in RBC plasma membrane following 30 min incubation of RBC in 40 μM CHOL (Jena and Lee, 2010) . These studies demonstrated the incorporation of exogenous cholesterol into RBC membrane. Similarly, to determine the optimal dose of the various compounds to be used in the study, dose-response experiments were performed. 40 μM Mas, which was previously demonstrated (Jena and Lee, 2010) to maximally stimulate rapid water entry into RBC, was used in the study.
To determine the effect of high cholesterol on AQP1 function in RBC, the transport of gases through the RBC membrane was determined (Fig. 1) . In an earlier study it had been demonstrated that the negative surface charge of RBC, deduced from their zeta potential measured using a ZetaSizer instrument, became less negative following exposure to carbon dioxide (Jena and Lee, 2010) . When CO 2 enters the cell, the carbonic acid generated within results in the neutralization of the net negative charge of the RBC membrane. The more CO 2 enters, the more positive the membrane potential of the RBC membrane becomes. Similarly, using the pHsensitive dye BCESF (Fig. 1) , the transport of CO 2 through AQP1 at the RBC membrane was further demonstrated. The BCESF results demonstrate that the AQP1 inhibitor HgCl 2 blocks CO 2 entry, preventing RBC acidification. Figure 1 . The pH-sensitive dye (BCESF: 2',7'-bis-2-carboxyethyl-5-6-carboxyfluorescein) used to demonstrate CO 2 transport through AQP1 at the RBC membrane. The AQP1 inhibitor HgCl 2 blocks CO 2 entry, preventing RBC acidification. Similarly, cholesterol blocks the entry of CO 2 into RBC. Data represents one of ten experiments.
Fluorescence intensity [FI] (arbitrary units)
Wavelength / nm pH decrease = FI increase Similarly, CHOL blocks the entry of CO 2 into RBC as effectively as does HgCl 2 . These results demonstrate that the increase in RBC membrane cholesterol is detrimental to CO 2 entry into RBC, as demonstrated by the near abrogation of RBC membrane charge neutralization and acidification compared to control RBC.
Next, the presence and effect of potassium (K + ) and chloride (Cl -) ion channels, and vH-ATPase in the RBC membrane, and their association with the water channel AQP1, were determined (Fig. 2) . Immunoblot and immunoprecipitation assays demonstrated the presence and association of vH-ATPase, KiR6.1 (potassium channel), and CLC3 (chloride channel) with AQP1 at the RBC membrane (Fig. 2) . Blockers of vH-ATPase, and of the K + and Cl -ion channels, on Mas-induced RBC volume changes were further determined using DLS (Figs 3-5) . Studies using the chloride channel inhibitor (DIDS), the potassium channel inhibitor (GLY) and the vHATPase inhibitor (Bafilomysin) on Mas-induced water entry into RBC demonstrated a dose-dependent inhibition of water entry in presence of DIDS, as opposed to a dose-dependent stimulation of RBC water entry in the presence of GLY and Bafilomycin (Fig. 3) . These functional studies further confirmed the presence of vHATPase and potassium and chloride channels at the RBC membrane, and their interaction in the regulation of AQP1, as demonstrated through the immunoblot anlysis (Fig. 2) . These studies (Fig. 4) further demonstrate that rapid water gating and consequent swelling of isolated RBC is impaired by high cholesterol and ameliorated by the potassium channel inhibitor GLY.
To determine the signalling pathway of AQP1 regulation at the RBC membrane, various application sequences of 40 μM of either the chloride or potassium channel inhibitors, or the PLA2 inhibitor, on Mas-induced RBC water entry and swelling were carried out (Fig. 5) . Figure 2 . Potassium and chloride channels are associated with AQP1 at the RBC membrane. Ten μg of total RBC membrane (RBCM) protein solubilized in 1% Triton-Lubrol, and 100 μg of RBCM immunoprecipitated using an AQP1-specific antibody (RBCM-IP-AQP1), was resolved using 10% SDS-PAGE, followed by electrotransfer to a nitrocellulose membrane, and probed using vH-ATPase, KiR6.1 (potassium channel), and CLC3 (chloride channel)-specific antibodies. Note the association of vH-ATPase, potassium and chloride channels with AQP1 at the RBC membrane.
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Figure 3. Dose-response of the chloride channel inhibitor diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS), the potassium channel inhibitor Glyburide and the vHATPase inhibitor Bafilomysin on mastoparan-induced water entry into RBC. Note the dose-dependent inhibition of water entry in presence of DIDS, as opposed to a dose-dependent stimulation of RBC water entry in the presence of Glyburide and Bafilomycin. The result further confirms the presence of vH-ATPase and potassium and chloride channels at the RBC membrane, and their interaction in the regulation of AQP1.
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Concentration / μM Figure 4 . Rapid water gating and consequent swelling of isolated RBC is impaired by high cholesterol and ameliorated by the potassium channel inhibitor Glyburide. On the left is a representative experiment demonstrating a time-dependent increase in DLS of RBC suspensions as a result of swelling due to rapid water entry following exposure to mastoparan (Mas). Note inhibition of rapid water entry following exposure to the chloride channel blocker diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS), and stimulation in the presence of the potassium channel blocker Glyburide (GLY). Note that the stimulatory effect of Glyburide persists even in the presence of excess membrane cholesterol (depicted in red, colour online). Data represents %-increase in dynamic light scattering (DLS) intensity from isolated RBC in the presence of various modulators. Data is obtained from 3 experiments with 8-15 points per experiment (*, P < 0.01).
Percent-increase in DLS intensity * P < 0.01
When RBC are exposed to DIDS followed by GLY, as opposed to GLY followed by DIDS, only the former sequence was found to be significantly inhibitory, suggesting that in the signalling cascade involved in G-protein mediated AQP1 stimulation, the chloride channel precedes the potassium channel. Similarly, if DIDS preceded exposure of RBCs to the PLA2 inhibitor ONO it was stimulatory, as opposed to the reverse sequence. This suggests that PLA2 is downstream of the chloride channel. Finally, since both the potassium channel inhibitor GLY and the PLA2 inhibitor ONO are stimulatory, and RBC exposure first to GLY followed by ONO are stimulatory but the reverse combination is not, it may be inferred that the potassium channel is upstream of PLA2. These studies, therefore, demonstrate that in the signalling cascade involved in the G-protein mediated regulation of AQP1 function the chloride channel precedes the potassium channel, followed by PLA2. The current findings build upon earlier studies (Abu-Hamdah et al., 2004) , in which the association of regulatory proteins such as G-proteins and PLA2 have been found to associate with AQP1. However, the key finding in the current study is the order-specificity of the signalling cascade in water and gas transport in RBC via the AQP1 channel. This new knowledge supports the Figure 5 . The various combinations of the sequential effect of 40 μM of either chloride, potassium or PLA2 inhibitors on mastoparan (Mas)-induced RBC water entry and swelling. Data represents %-increase over the control of RBC stimulated with Mas. Note that when RBC are exposed to DIDS followed by GLY as opposed to GLY followed by DIDS, only the former is significantly inhibitory, suggesting that in the signalling cascade involved in the G-protein-mediated AQP1 stimulation, the chloride channel precedes the potassium channel. Similarly, if DIDS precedes exposure of RBCs to the PLA2 inhibitor ONO-RS-082 (ONO) it is stimulatory, as opposed to the reverse sequence. This suggests that PLA2 is downstream of the chloride channel. Finally, since both the potassium channel inhibitor GLY and the PLA2 inhibitor ONO are stimulatory; and RBC exposure first to GLY followed by ONO is more stimulatory than the reverse combination, it can be inferred that the potassium channel is upstream of PLA2. These results therefore suggest that in the signalling cascade involved in the G-protein-mediated AQP1 stimulation, the chloride channel precedes the potassium channel, followed by PLA2. Data represent one of 3 separate experiments, with 8-15 value points per experiment that were averaged and represented with standard deviation (*, P < 0.05; **, P < 0.001).
Percentage increase in scattering intensity * P < 0.05 * * P < 0.001 possible use of Glyburide and ONO-RS-082 as therapeutic agents to ameliorate the detriment of elevated RBC membrane cholesterol on water and gas transport into and out of the cell.
SUMMARY AND CONCLUSION
This study demonstrates that elevated cholesterol in the RBC plasma membrane impairs both water and CO 2 transport into the cell. With respect to the impact of cholesterol on molecular transport in RBC, these results further confirm the initial findings of Steinbach et al. (1974) involving oxygen transport, and provide not only further evidence for an AQP1-specific dysfunction caused by cholesterol in RBC but also an understanding of the signalling cascade leading to function and dysfunction of AQP1. Through the further development of our understanding of this signalling cascade, we were also able to determine that the potassium channel blocker Glyburide and the PLA2 inhibitor ONO-RS-O82 are both able to ameliorate the detrimental effect of elevated cholesterol on RBC function. Therefore, potassium and PLA2 inhibitors could be used as potential drugs to treat elevated cholesterol-induced impairment of RBC function. Glyburide is currently being used as a drug to treat type 2 diabetes, and therefore potentially could be used to treat detriments resulting from elevated blood cholesterol. Similarly, the PLA2 inhibitor "Darapladib" is currently under development by GlaxoSmithKline as an anti-atherosclerosis agent to treat coronary heart disease. Furthermore, since the vH-ATPase inhibitor Bafilomycin potentiates active transport of water into RBC, further studies are being carried out to determine its potential use as a drug to ameliorate RBC dysfunction due to elevated plasma cholesterol.
